中文名称: Jtc-801
英文名称: Jtc-801
CAS No: 244218-51-7
分子式: C26H26ClN3O2
分子量: 448.00
J70002 Jtc-801 ≥98% (psaitong)
包装规格:
5mg 25mg in glass bottle
溶解性:
溶于DMSO
产品描述:

基本信息

产品编号:

J70002

产品名称:

Jtc-801

CAS:

244218-51-7

 

储存条件

粉末

-20℃

四年

 

 

分子式:

C26H26ClN3O2

溶于液体

-80℃

6个月

分子量:

448.00

-20℃

1个月

化学名: 

N-(4-amino-2-methylquinolin-6-yl)-2-((4-ethylphenoxy)methyl)benzamide hydrochloride

Solubility (25°C):

 

体外:

 

DMSO

90mg/mL (200.91mM)

Ethanol

31mg/mL (69.2mM)

Water

Insoluble

体内(现配现用):

0.5% methylcellulose

30mg/mL

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.2323mL

11.1617mL

22.3234mL

5mM

0.4465mL

2.2323mL

4.4647mL

10mM

0.2232mL

1.1162mL

2.2323mL

50mM

0.0446mL

0.2232mL

0.4465mL

 

生物活性

产品描述

JTC-801 是一种具有选择性的 opioid receptor-like1 (ORL1) receptor 抑制剂,其 Ki 值为 8.2nM。

靶点

Opioid receptor-like1 (ORL1) 

94nM

 

体外研究

JTC-801 inhibits [3H]-nociceptin binding to ORL1 receptor expressed in HeLa cells with an IC50 value of 94±8.6nm at a [3H]-nociceptin concentration of 50pM.JTC-801 weakly inhibits the binding of the ligands to human δ receptor (IC50>10μM),κ receptor (IC50>10μM),and μ receptor (IC50=325nM).In rat cerebrocortical membrane,JTC-801 inhibits ORL1 receptor (IC50=472nM) and μ receptor (IC50=1831nM).JTC-801 at a concentration of 10μM reverses the inhibitory action of nociceptin against forskolin-induced increase in cyclic AMP level (IC50:2.58μM,1nM of nociceptin used).JTC-801 alone does not affect the the production of cyclic AMP.The affinity of JTC-801 for ORL1 receptor,human opioid μ-,κ-,and δ-receptors is 8.2nM,102.9nM,1057.5nM and 8647.2nM.

体内研究

JTC-801 (≥0.01mg/kg,i.v. or 1mg/kg,p.o.) antagonizes the nociceptin-induced allodynia in mice.In mouse hot-plate test,JTC-801 prolongs escape response latency (ERL) to exposed heat stimulus with minimum effective doses (MED) of 0.01mg/kg by i.v.or 1mg/kg by p.o.In the rat formalin test,JTC-801 reduces both the first and second phases of the nociceptive response with MED of 0.01mg/kg by i.v.administration or 1mg/kg by p.o.administration.This anti-nociceptive action of JTC-801 is not inhibited by naloxone (10mg/kg,s.c.).JTC-801 antagonizes the ORL1 receptor response,and has efficacious and potent anti-nociceptive effects in acute pain animal models not only by intravenous injection but also oral administration.JTC-801 (0.3mg/kg) decreases allodynia induced by the intrathecal injection of nociceptin in mice.JTC801 (6mg/kg i.p.,once daily) reverses SPS-induced mechanical allodynia,thermal hyperalgesia,anxiety-like behaviour and hypocortisolism.JTC-801 treatment also reverses NOP receptor protein and mRNA up-regulation in amygdala and PAG.JTC801 blocks elevated N/OFQ levels in serum,CSF,PAG and hippocampus at day 21 of SPS.JTC-801 (0.05-5mg/kg,i.p.) supresses the the analgesic effect of N2O in 129Sv mice by the writhing test and tail flick test.

 

推荐实验方法(仅供参考)

激酶实验:

A suspension of membranes from human μ-opioid receptor-expressing CHO-K1 cells in 50mM Tris-HCl buffer (pH 7.4) containing 5mM MgCl2 and 10% sucrose is incubated at room temperature for 2.5h with 0.33nM 3H-labeled diprenorphine and various concentrations of JTC-801.The membranes are collected by filtration using Whatman 934-AH,and radioactivity is counted with a TopCount A9912V scintillation counter. Nonspecific binding (6.4%) is determined with 10μM naloxone.Specific binding is calculated by subtracting nonspecific binding from the total binding.Data are the mean±SE (n=3).

 

动物实验:

 

The antagonistic effect of naloxone,a non-specific opioid antagonist,on the anti-nociceptive effect of JTC-801 and morphine is examined by formalin stimulation test.Limb licking response is induced by subcutaneous injection of 50μL of 5% formalin to the left hind limb of each rat.The first 5 min (from immediately after the injection of formalin) and the subsequent 15 min (15-30 min post-injection) are designated as the first and second phases,respectively.The limb licking time during each of the phases is measured and used as an indicator of pain.Fifteen min before the injection of formalin,naloxone (10mg/kg,dissolved in physiological saline) is given subcutaneously.Five min before the injection of formalin,JTC-801 and morphine are dissolved in 5% sorbitol and given into the tail vein at doses of 0.03 and 1.0mg/kg,respectively.JTC-801 (3.0mg/kg) and morphine (30mg/kg) are administered orally 60 min before the formalin injection.

保存条件:
-20℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):